Loading clinical trials...
Loading clinical trials...
A Phase II Study of EL625 in Patients in Persistent Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Conditions
Interventions
cenersen sodium
Rituximab
+2 more
Locations
1
United States
Duke University Medical Center
Durham, North Carolina, United States
Start Date
February 1, 2008
Primary Completion Date
August 1, 2011
Completion Date
May 1, 2012
Last Updated
November 28, 2012
NCT07162181
NCT07218341
NCT04210219
NCT03190330
NCT06205290
NCT00081809
Lead Sponsor
David Rizzieri
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions